Inventor · disambiguated record
Laurence Dube
Also filed as: DUBE LAURENCE · DUBÉ LAURENCE
11 granted patents·2 pending applications·47 citations·filing 2003–2024
88Inventor score
Files withBRISTOL MYERS SQUIBB CO6MERCK FROSST CANADA LTD3BAYLY CHRISTOPHER I2MERCK FROSST CANADA1MERCK FROST CANADA LTD1
Top patents by PatentIndex Score
13 records- 0193US10047103B2Imidazothiadiazole and imidazopyrazine derivatives as protease activated receptor 4 (PAR4) inhibitors for treating platelet aggregationBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Aug 14, 2018·11 cites·22 claims
- 0292US10822343B2Imidazothiadiazole and imidazopyrazine derivatives as protease activated receptor4 (PAR4) inhibitors for treating platelet aggregationBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Nov 3, 2020·4 cites·15 claims
- 0392US10428077B2Imidazothiadiazole and imidazopyrazine derivatives as protease activated receptor4 (PAR4) inhibitors for treating platelet aggregationBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Oct 1, 2019·8 cites·9 claims
- 0490US9688695B2Imidazothiadiazole and imidazopyrazine derivatives as protease activated receptor 4 (PAR4) inhibitors for treating platelet aggregationBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Jun 27, 2017·11 cites·51 claims
- 0585US2025002497A1Imidazothiadiazole and imidazopyrazine derivatives as protease activated receptor 4 (par4) inhibitors for treating platelet aggregationBRISTOL MYERS SQUIBB CO·Filed 2024·Application pending·0 cites
- 0680US12084452B2Imidazothiadiazole and imidazopyrazine derivatives as protease activated receptor 4 (PAR4) inhibitors for treating platelet aggregationBRISTOL MYERS SQUIBB CO·Filed 2022·Granted Sep 10, 2024·0 cites·6 claims
- 0772US7153968B28-(biaryl)quinoline PDE4 inhibitorsMERCK FROSST CANADA LTD·Filed 2003·Granted Dec 26, 2006·7 cites·23 claims
- 0869US8063105B2Renin inhibitorsBAYLY CHRISTOPHER I·Filed 2006·Granted Nov 22, 2011·1 cites·8 claims
- 0966US7482456B28-(3-Biaryl)phenylquinoline phosphodiesterase-4 inhibitorsMERCK FROSST CANADA·Filed 2004·Granted Jan 27, 2009·3 cites·25 claims
- 1063US7144896B2Hetero-bridge substituted 8-arylquinoline pde4 inhibitorsMERCK FROSST CANADA LTD·Filed 2003·Granted Dec 5, 2006·2 cites·27 claims
- 1152US7238706B24-oxo-1-(3-substituted phenyl-1,4-dihydro-1,8-naphthyridine-3-carboxamide phosphodiesterase-4 inhibitorsMERCK FROSST CANADA LTD·Filed 2004·Granted Jul 3, 2007·0 cites·15 claims
- 1245US7342024B24-Oxo-1-3-substituted phenyl-1,4-dihydro-1,8-naphthyridine-3-carboxamide phosphodiesterase-4 inhibitorsMERCK FROST CANADA LTD·Filed 2003·Granted Mar 11, 2008·0 cites·12 claims
- 1344US2012046293A1Renin inhibitorsBAYLY CHRISTOPHER I·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Laurence Dube files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →